Cargando…
Immunotherapy for Medulloblastoma: Current Perspectives
BACKGROUND: Immune-mediated therapies have transformed the treatment of metastatic melanoma and renal, bladder, and both small and non-small cell lung carcinomas. However, immunotherapy is yet to demonstrate dramatic results in brain tumors like medulloblastoma for a variety of reasons. Recent pre-c...
Autores principales: | Kabir, Tanvir F, Kunos, Charles A, Villano, John L, Chauhan, Aman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182450/ https://www.ncbi.nlm.nih.gov/pubmed/32368525 http://dx.doi.org/10.2147/ITT.S198162 |
Ejemplares similares
-
Immunotherapy in Medulloblastoma: Current State of Research, Challenges, and Future Perspectives
por: Voskamp, Marije J., et al.
Publicado: (2021) -
Prognostic and predictive factors associated with ipilimumab-related adverse events: a retrospective analysis of 11 NCI-sponsored phase I clinical trials
por: Chauhan, Aman, et al.
Publicado: (2020) -
Medulloblastoma: Current Perspectives and Recent Advances
por: Choi, Jung Yoon
Publicado: (2023) -
Cellular immunotherapy for medulloblastoma
por: Schakelaar, Michael Y, et al.
Publicado: (2022) -
Adult Medulloblastoma: Updates on Current Management and Future Perspectives
por: Franceschi, Enrico, et al.
Publicado: (2022)